# Italy Catheters Active Implantable CDMO Market > Italy Catheter Active Implantable CDMO Market Research Report By Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, Others) and By End-Users (Medical Device OEM Companies, Academic and Research Institutes, Government Agencies) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 10.67% - **2024:** $ 224.7 Million - **2025:** $ 248.68 Million - **2035:** $ 685.2 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Smiths Medical (US), Cook Medical (US), ConvaTec Group (GB) **Report ID:** MRFR/MED/48372-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/italy-catheters-active-implantable-cdmo-market-50129 --- ## Market Summary ## **Italy Catheter Active Implantable CDMO Market Overview** As per MRFR analysis, the Italy Catheter Active Implantable CDMO Market Size was estimated at 291.06 (USD Million) in 2023.The Italy Catheter Active Implantable CDMO Market Industry is expected to grow from 314.58(USD Million) in 2024 to 1,030.92 (USD Million) by 2035. The Italy Catheter Active Implantable CDMO Market CAGR (growth rate) is expected to be around 11.394% during the forecast period (2025 - 2035). ## **Key Italy Catheter Active Implantable CDMO Market Trends Highlighted** The Italy Catheter Active Implantable CDMO Market is growing significantly attributed to chronic diseases with long-term treatment options and catheters as a growing implantable technology. In addition, Italy's aging population further drives this demand and the implantation rate of catheters. There is greater focus on customized medical devices which creates demand for customized solutions from CDMOs. These trends increase opportunities in the market as local manufacturers seek to develop and innovative advanced catheters that enhance comfort and treatment outcomes for patients. Italy has numerous established Medical devices which requires further research and development in the active implantable technologies. Alongside an enabling regulatory framework for these technologies, partnerships between CDMOs and healthcare providers will have a greater impact on market share. Recently, there is increased focus on Italian CDMOs automating manufacturing systems which improves efficiency in production. There is also a shift towards sustainable catheter manufacturing and ecofriendly materials. With providers moving toward integrated care, it seems this will increase the need for new innovations for devices that guarantee a flawless patient journey. Such changes create a stunning opportunity for the Italy Catheter Active Implantable CDMO Market to grow and develop in accordance with the country’s health care system. ## **Italy Catheter Active Implantable CDMO Market Drivers** Growing Aging Population Italy's aging population is a significant driver for the Italy Catheter Active Implantable Contract Development and Manufacturing Organization Market. According to the National Institute of Statistics (ISTAT), by 2040, the proportion of people over 65 years in Italy is expected to rise to 25.4%, increasing the demand for active implantable catheters, particularly for chronic conditions like cardiovascular diseases. As organizations such as Sorin Group and Medtronic expand their product lines, the ability to provide innovative implantable devices becomes increasingly crucial.This demographic shift and related health trends indicate sustained growth in the active implantable catheter segment, compelling CDMO services to support rising demand in this aging population sector. Research estimates that the healthcare expenditures will likely increase to approximately 10% of the GDP due to the corresponding rise in long-term care needs, bolstering opportunities within the Italy Catheter Active Implantable CDMO Market. Increased Prevalence of Chronic Diseases The rising prevalence of chronic diseases such as diabetes and hypertension in Italy has been a key driver for the Italy Catheter Active Implantable CDMO Market. According to the Italian Ministry of Health, nearly 10% of the adult population is diabetic, noted to double over the last two decades. This escalating epidemic necessitates advanced medical devices like implantable catheters for monitoring and treatment. Companies such as Teleflex and Abbott are increasingly investing in technologies that enhance catheter functionality, which propels the market forward. As the Italian healthcare system adapts to manage these chronic conditions, the demand for reliable CDMO services to manufacture specialized equipment is set to surge. Technological Advancements in Medical Devices Ongoing technological innovations in medical devices are one of the substantial drivers behind the Italy Catheter Active Implantable CDMO Market growth. The Italian pharmaceutical and medical technology industry is recognized for its swift adaptation to advanced technologies, leveraging expertise from research institutions like the Italian Institute of Technology (IIT). Recent advancements, including miniaturization and integration of IoT in catheter technology, have led to more effective patient management systems. A notable part of this progress has been propelled by manufacturers like Boston Scientific who continue to innovate in the catheter space. This relentless pursuit of technology advancement amplifies the requirement for CDMO partnerships to pivot swiftly with the advancements, ensuring compliance and high quality in manufacturing processes. Regulatory Support for Medical Device Innovation Regulatory bodies in Italy have been enhancing policies to support innovation within the medical device sector, influencing the growth of the Italy Catheter Active Implantable CDMO Market. The Ministry of Health in Italy has established streamlined processes to accelerate the approval times for new medical devices, which aids in faster time-to-market for new products.  This regulatory shift encourages investment from established organizations such as Johnson & Johnson and Philips, which can capitalize on quicker innovations in their catheter technologies.The focus on efficiency and compliance aligns with European medical device regulations as well, driving CDMOs to align their services with the latest standards, ultimately enhancing the market's growth potential. ## **Italy Catheter Active Implantable CDMO Market Segment Insights** ### **Catheter Active Implantable CDMO Market Service Category Insights** The Italy Catheter Active Implantable CDMO Market encompasses a diverse array of service categories that play a crucial role in the healthcare landscape. The market exhibits substantial growth potential driven by advancements in medical technology and increasing prevalence of chronic diseases requiring the use of catheters and active implantable devices. Specifically, catheters serve an essential function in various medical procedures, allowing for precise and effective patient care. The significance of active implantable devices is underscored by their ability to monitor and treat conditions such as cardiac disorders, making them integral to modern therapeutic practices.In addition to these, endoscopy devices are becoming increasingly vital as they facilitate minimally invasive procedures, which are gaining preference due to reduced recovery times and lower risks associated with surgery.  Other services within the market contribute to the overall ecosystem by addressing specific medical needs through innovative solutions. Each service category not only supports the market's growth but also enhances patient outcomes, aligning with Italy's healthcare initiatives aimed at improving medical standards.The rapid evolution of these medical devices and the rise in Research and Development activities indicate a robust pipeline of future innovations that could redefine standards of care. Factors such as the aging population in Italy and the increasing incidence of lifestyle-related diseases further support the sustained demand for these services. As the Italy Catheter Active Implantable CDMO Market continues to expand, healthcare facilities are likely to invest significantly in these advanced technologies, which are expected to dominate various segments due to their ability to provide effective treatment options. Statistical data showcases the upward trajectory of these service categories, highlighting a growing awareness among healthcare providers regarding the benefits of adopting advanced medical devices. Moreover, collaborations between manufacturers and healthcare institutions to enhance service delivery models will likely introduce improved therapies and potentially address challenges associated with the integration of new technologies into clinical practices. Overall, the service category segment within this market reflects a multifaceted landscape where ongoing advancements, regulatory policies, and evolving patient needs coalesce to create a dynamic environment poised for continuous growth in Italy’s healthcare sector. ### **Catheter Active Implantable CDMO Market End-Users Insights** The End-Users segment of the Italy Catheter Active Implantable CDMO Market plays a pivotal role, comprising diverse sectors that drive innovation and application in the healthcare industry. Medical Device Original Equipment Manufacturers (OEM) are crucial players in this market, as they leverage advanced technologies and efficient manufacturing processes to develop high-quality catheter systems, ultimately enhancing patient outcomes.  Academic and Research Institutes contribute significantly to the evolution of catheter technologies, focusing on research and development initiatives that lead to ground-breaking solutions in treatment methodologies.Moreover, Government Agencies play a vital role by establishing stringent regulations and guidelines, thus ensuring the safety and efficacy of implantable devices. This regulatory landscape can both challenge and stimulate market growth by encouraging compliance and fostering innovation within the sector.  Italy's strong emphasis on healthcare advancements ensures a collaborative environment among these end-users, facilitating the continuous improvement and adoption of catheter-based technologies that cater to a growing patient base. Thus, the interdependence of these segments within the Italy Catheter Active Implantable CDMO Market highlights their importance in driving advancements and addressing the evolving healthcare demands. **Italy Catheter Active Implantable CDMO Market Key Players and Competitive Insights:** The Italy Catheter Active Implantable CDMO Market is characterized by a dynamic and competitive landscape, influenced by advancements in medical technology and increasing demand for specialized medical devices. Contract Development and Manufacturing Organizations (CDMO) play a crucial role in this sector, as they provide essential services including research, development, and manufacturing expertise to companies producing active implantable catheters. The market is defined by a strong emphasis on innovation, regulatory compliance, and the capacity to meet the specific needs of healthcare providers.  As the demand for more sophisticated and effective medical devices continues to rise, CDMOs are expected to enhance their operational capabilities, ensuring they can meet the evolving requirements of their clients, particularly in highly regulated environments such as Italy.Cook Medical holds a significant presence in the Italy Catheter Active Implantable CDMO Market, driven by its commitment to innovation and quality. The company's strengths lie in its extensive product portfolio, which includes a range of advanced catheter technologies designed for various medical applications. Cook Medical emphasizes its ability to deliver tailored solutions that meet the stringent regulatory standards of the Italian healthcare market.  Moreover, the company has established strong relationships with local healthcare providers and institutions, enhancing its competitive edge through collaborative efforts in research and development. Cook Medical's operational efficiencies, combined with its focus on customer service, position it as a formidable player in the landscape of active implantable catheters in Italy.Conmed Corporation offers a compelling presence in the Italy Catheter Active Implantable CDMO Market, supported by a diverse array of products and services tailored to meet the needs of this sector. The company is recognized for its expertise in surgical instrumentation and its commitment to innovation, which is evident in its wide range of active implantable catheters.  Conmed Corporation has also pursued strategic mergers and acquisitions to strengthen its market position and broaden its product offerings, allowing it to penetrate various segments within the Italian healthcare system effectively. Its strengths lie in its robust research and development capabilities, ensuring the delivery of cutting-edge solutions that comply with Italian regulatory standards while also addressing the demand for efficacy and safety in medical devices. Conmed Corporation's established market presence and reputation for quality further consolidate its position in the Italian catheter landscape, making it a vital competitor in the active implantable CDMO space. **Key Companies in the Italy Catheter Active Implantable CDMO Market Include:** **Italy Catheter Active Implantable CDMO Market Industry Developments** Recent developments in the Italy Catheter Active Implantable Contract Development and Manufacturing Organization (CDMO) market have seen increased investments and focus on innovation. Notably, in October 2023, Medtronic introduced new catheter technology aimed at enhancing patient outcomes, spotlighting its commitment to Research and Development in Italy. Meanwhile, Conmed Corporation has strengthened its operational capabilities through the establishment of an advanced manufacturing facility in the Lombardy region, indicating a growing trend of domestic production. In terms of mergers and acquisitions, Cook Medical announced its acquisition of a local Italian company, enhancing its product portfolio, with reports surfacing in September 2023 regarding this strategic move.  Moreover, Boston Scientific has expanded its market presence with the launch of a new line of catheters, aimed at cardiac procedures, contributing positively to market growth. The Italy Catheter Active Implantable CDMO market is seeing significant growth, driven by technological advancements and an increasing patient demographic, alongside established companies like Abbott Laboratories and Teleflex Incorporated enhancing their research initiatives to meet the burgeoning demand in the healthcare sector. Over the past few years, Italy has positioned itself as a key player in the medical device manufacturing sector, reflecting strong government support and investment in health technologies. ## **Italy Catheter Active Implantable CDMO Market Segmentation Insights** ### **Catheter Active Implantable CDMO Market Service Category****Outlook** ### **Catheter Active Implantable CDMO Market End-Users****Outlook** ## Market Drivers ### Aging Population and Chronic Diseases Italy's demographic shift towards an aging population is significantly impacting the catheters active-implantable-cdmo market. With an increasing number of elderly individuals, the prevalence of chronic diseases such as cardiovascular conditions and diabetes is on the rise. Reports indicate that nearly 25% of the Italian population is over 65 years old, leading to a higher demand for medical devices, including catheters. This demographic trend necessitates the development of specialized catheters that cater to the unique needs of older patients. As healthcare systems adapt to these changes, the catheters active-implantable-cdmo market is likely to experience substantial growth driven by the need for effective management of chronic health issues. ### Investment in Healthcare Infrastructure The Italian government's commitment to enhancing healthcare infrastructure is a pivotal driver for the catheters active-implantable-cdmo market. Recent initiatives have focused on upgrading medical facilities and expanding access to advanced medical technologies. With an investment of approximately €2 billion allocated for healthcare improvements, the market is poised for growth. This financial support is expected to facilitate the adoption of innovative catheter technologies, thereby improving patient outcomes. Furthermore, as hospitals and clinics modernize their equipment, the demand for high-quality catheters is likely to increase, further propelling the catheters active-implantable-cdmo market. ### Technological Integration in Healthcare The integration of advanced technologies in healthcare is reshaping the catheters active-implantable-cdmo market. Innovations such as telemedicine, artificial intelligence, and data analytics are being increasingly utilized to enhance patient care and streamline medical processes. In Italy, healthcare providers are adopting these technologies to improve the efficiency of catheter-related procedures. This integration not only enhances the accuracy of diagnoses but also optimizes the management of catheter usage. As a result, the demand for technologically advanced catheters is expected to rise, driving growth in the catheters active-implantable-cdmo market. The potential for improved patient outcomes through these innovations is likely to further stimulate market expansion. ### Growing Awareness of Health and Wellness There is a notable increase in health consciousness among the Italian population, which is influencing the catheters active-implantable-cdmo market. As individuals become more aware of the importance of preventive healthcare, there is a corresponding rise in the utilization of medical devices, including catheters. This trend is supported by educational campaigns and initiatives aimed at promoting health and wellness. Consequently, healthcare providers are more inclined to recommend advanced catheter solutions for various medical conditions. The catheters active-implantable-cdmo market is likely to benefit from this heightened awareness, as patients seek out effective and reliable medical devices to manage their health. ### Rising Demand for Minimally Invasive Procedures The increasing preference for minimally invasive procedures in Italy is driving the catheters active-implantable-cdmo market. Patients and healthcare providers are gravitating towards techniques that reduce recovery time and minimize surgical risks. This trend is reflected in the growing number of procedures performed, with estimates suggesting a rise of approximately 15% annually. As a result, manufacturers are compelled to innovate and enhance their product offerings to meet the evolving needs of healthcare professionals. The demand for advanced catheter technologies, which facilitate these procedures, is likely to bolster the market further. Consequently, the catheters active-implantable-cdmo market is positioned to benefit from this shift towards less invasive treatment options. ## Future Outlook The [Catheters Active Implantable CDMO Market](https://www.marketresearchfuture.com/reports/catheters-active-implantable-cdmo-market-26788) is projected to grow at a 10.67% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of customized catheter solutions for niche medical applications. - Expansion of telehealth services for remote patient monitoring. - Investment in biodegradable materials for sustainable catheter production. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic investments. ## Segment Insights ### By Service Segment: Catheters (Largest) vs. Active Implantable Devices (Fastest-Growing) The market share distribution within the segment values demonstrates that catheters hold a significant position, accounting for a substantial portion of the overall market. Active implantable devices and endoscopy devices are also key players, with active implantable devices emerging as a contender with robust market growth potential, although their share is not as large as catheters. In terms of growth trends, the service segment is witnessing an upward trajectory fueled by advancements in technology and increasing demand for minimally invasive procedures. The rising prevalence of chronic diseases is propelling the usage of catheters and active implantable devices, while innovation in endoscopy devices is carving out new niches in the market, making it essential to focus on these areas for future expansion. Catheters (Dominant) vs. Active Implantable Devices (Emerging) Catheters are the dominant force in the service segment, known for their versatility and wide range of applications in medical procedures. Their established presence in the market is supported by a consistent demand for various types of catheters, including vascular and urinary options. On the other hand, active implantable devices represent an emerging market segment with significant potential for growth. As technology evolves, features such as remote monitoring and biocompatibility are enhancing the appeal of active implantable devices. The increase in surgical procedures and a growing geriatric population further drive the adoption of these innovative medical devices, indicating a promising trajectory for both categories. ### By End User: Medical Device OEM Companies (Largest) vs. Academic and Research Institutes (Fastest-Growing) In the Italy catheters active-implantable-cdmo market, Medical Device OEM Companies represent the largest share, reflecting their established role as major players in the industry. These companies leverage their extensive distribution networks and robust manufacturing capabilities, positioning themselves as primary contributors to market stability and growth. In contrast, Academic and Research Institutes are rapidly expanding their footprint, driven by innovations in medical technology and an increasing focus on research and development. The growth trends within this segment are primarily driven by advancements in technology and regulatory support for innovative medical devices. Government Agencies play a pivotal role in funding and supporting research initiatives, thereby bolstering the capabilities of Academic and Research Institutes. The convergence of scientific research with practical applications in the healthcare sector is fueling emerging opportunities and market expansion, spearheaded by collaborations between these entities. Medical Device OEM Companies (Dominant) vs. Academic and Research Institutes (Emerging) Medical Device OEM Companies have cemented their position as dominant players in the Italy catheters active-implantable-cdmo market through their vast experience and comprehensive understanding of market needs. They ensure product quality and compliance with stringent regulations, fostering trust with healthcare providers. In contrast, Academic and Research Institutes are emerging as vital contributors to innovation within the market. These institutions are pivotal in developing new technologies and methodologies, driven by academic research and partnerships with healthcare professionals. Their agility in adapting to new scientific discoveries enables them to bring forth cutting-edge solutions, thus complementing the stable offerings from OEMs and enhancing patient care outcomes. ## Competitive Benchmarking The catheters active-implantable-cdmo market in Italy is characterized by a dynamic competitive landscape, driven by innovation, regulatory advancements, and increasing demand for minimally invasive procedures. Major players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on technological innovation, particularly in developing advanced catheter systems that integrate digital health solutions. Meanwhile, Boston Scientific (US) emphasizes strategic partnerships to expand its product portfolio and enhance its manufacturing capabilities, thereby positioning itself as a leader in the market. Abbott Laboratories (US) is also notable for its commitment to research and development, aiming to introduce cutting-edge products that cater to evolving patient needs. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological advancement and strategic collaborations.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and innovations, although it also necessitates that companies continuously adapt to maintain their competitive edge. The collective influence of these major players shapes the market, as they vie for leadership through various strategic initiatives. In October Medtronic (US) announced the launch of a new catheter system designed to improve patient outcomes in cardiac procedures. This development is significant as it not only showcases Medtronic's commitment to innovation but also reinforces its position in a highly competitive segment of the market. The introduction of this advanced system is expected to enhance procedural efficiency and patient safety, potentially leading to increased market share. In September Boston Scientific (US) entered into a strategic partnership with a leading Italian medical device manufacturer to co-develop next-generation catheter technologies. This collaboration is indicative of Boston Scientific's strategy to leverage local expertise and resources, thereby accelerating product development and market entry. Such partnerships are likely to enhance the company's competitive positioning by enabling it to respond more effectively to regional market demands. In August Abbott Laboratories (US) expanded its manufacturing capabilities in Italy, investing €50 million in a new facility dedicated to the production of advanced catheter systems. This investment underscores Abbott's focus on enhancing its operational efficiency and meeting the growing demand for innovative medical devices. By increasing its production capacity, Abbott is well-positioned to capitalize on emerging market opportunities and strengthen its competitive stance. As of November current trends in the catheters active-implantable-cdmo market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise to drive innovation. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological innovation, supply chain reliability, and enhanced patient outcomes. This shift suggests that companies that prioritize these aspects are likely to gain a competitive advantage in the rapidly evolving market. ## Recent News & Developments Recent developments in the Italy Catheter Active Implantable Contract Development and Manufacturing Organization (CDMO) market have seen increased investments and focus on innovation. Notably, in October 2023, Medtronic introduced new catheter technology aimed at enhancing patient outcomes, spotlighting its commitment to Research and Development in Italy. Meanwhile, Conmed Corporation has strengthened its operational capabilities through the establishment of an advanced manufacturing facility in the Lombardy region, indicating a growing trend of domestic production. In terms of mergers and acquisitions, Cook Medical announced its acquisition of a local Italian company, enhancing its product portfolio, with reports surfacing in September 2023 regarding this strategic move.  Moreover, Boston Scientific has expanded its market presence with the launch of a new line of catheters, aimed at cardiac procedures, contributing positively to market growth. The Italy Catheter Active Implantable CDMO market is seeing significant growth, driven by technological advancements and an increasing patient demographic, alongside established companies like Abbott Laboratories and Teleflex Incorporated enhancing their research initiatives to meet the burgeoning demand in the healthcare sector. Over the past few years, Italy has positioned itself as a key player in the medical device manufacturing sector, reflecting strong government support and investment in health technologies. ## Report Scope | MARKET SIZE 2024 | 224.7(USD Million) | | --- | --- | | MARKET SIZE 2025 | 248.68(USD Million) | | MARKET SIZE 2035 | 685.2(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.67% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Smiths Medical (US), Cook Medical (US), ConvaTec Group (GB) | | Segments Covered | Service Segment, End User | | Key Market Opportunities | Advancements in biocompatible materials enhance product performance in the catheters active-implantable-cdmo market. | | Key Market Dynamics | Rising demand for innovative catheter solutions drives competition among active-implantable contract development and manufacturing organizations. | | Countries Covered | Italy | ## Frequently Asked Questions **Q: What was the overall market valuation for the Italy catheters active-implantable-cdmo market in 2024?** A: The overall market valuation was $224.7 Million in 2024. **Q: What is the projected market valuation for the Italy catheters active-implantable-cdmo market by 2035?** A: The projected market valuation for 2035 is $685.2 Million. **Q: What is the expected CAGR for the Italy catheters active-implantable-cdmo market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 10.67%. **Q: Which companies are considered key players in the Italy catheters active-implantable-cdmo market?** A: Key players include Medtronic, Boston Scientific, Abbott Laboratories, Johnson & Johnson, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical, Cook Medical, and ConvaTec Group. **Q: What were the segment valuations for catheters in the service segment in 2024?** A: In 2024, the segment valuation for catheters in the service segment was $60.0 Million. **Q: What is the projected valuation for active implantable devices in the service segment by 2035?** A: The projected valuation for active implantable devices in the service segment by 2035 is $240.0 Million. **Q: How much did endoscopy devices generate in the service segment in 2024?** A: Endoscopy devices generated $84.7 Million in the service segment in 2024. **Q: What is the expected valuation for medical device OEM companies in the end user segment by 2035?** A: The expected valuation for medical device OEM companies in the end user segment by 2035 is $270.0 Million. **Q: What were the segment valuations for academic and research institutes in the end user segment in 2024?** A: In 2024, academic and research institutes had segment valuations of $60.0 Million in the end user segment. **Q: What is the projected valuation for government agencies in the end user segment by 2035?** A: The projected valuation for government agencies in the end user segment by 2035 is $235.2 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/italy-catheters-active-implantable-cdmo-market-50129*